Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | TDO2 | P48775 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | KCNA5 | P22460 | 4/20 | 0.43 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.43 |
| ▸ | CCR9 | P51686 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.41 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4592340 | 0.85 | KDM4E (0.41) | TRPV1IDO1TDO2KCNA5KCNN4 | |
| SCHEMBL2889939 | 0.82 | TRPV1 (0.47) | TRPV1KCNA5KCNN4KDM4EGAA | |
| SCHEMBL30832971 | 0.82 | KDM4E (0.48) | TRPV1KCNA5KCNN4CCR9KDM4E | |
| SCHEMBL7160604 | 0.82 | KDM4E (0.48) | TRPV1KCNA5KCNN4CCR9KDM4E | |
| SCHEMBL3719145 | 0.81 | TRPV1 (0.47) | TRPV1KDM4EGAARAB9ASMN1; SMN2 | |
| SCHEMBL17455924 | 0.81 | TRPV1 (0.46) | TRPV1KCNA5KCNN4KDM4EGAA | |
| SCHEMBL5093163 | 0.81 | KCNA5 (0.60) | IDO1TDO2KCNA5KCNN4CCR9 | |
| Hydrochloric Acid SCHEMBL9030551 | 0.80 | TRPV1 (0.46) | TRPV1KDM4EGAARAB9ASMN1; SMN2 | |
| SCHEMBL792165 | 0.80 | CCR9 (0.45) | TRPV1IDO1TDO2KCNA5KCNN4 | |
| SCHEMBL28279884 | 0.79 | PTGS2 (0.51) | TRPV1IDO1TDO2KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0799159-A1 | DECHLORINATION OF TCE WITH PALLADIZED IRON | Research Corporation Technologies, Inc (US) | 1997-10-08 | — | — | EP | claimed |
| US-5616253-A | Dechlorination of TCE with palladized iron | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-04-01 | — | — | US | claimed |
| WO-1996020137-A1 | DECHLORINATION OF TCE WITH PALLADIZED IRON | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-07-04 | — | — | WO | claimed |
| EP-3919056-B1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2024-08-28 | — | — | EP | disclosed |
| US-20230322704-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20230322704-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20230322704-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-10-12 | — | — | US | disclosed |
| US-11530191-B2 | Compounds and uses thereof for the modulation of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| US-11530191-B2 | Compounds and uses thereof for the modulation of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| EP-3919056-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | Global Blood Therapeutics, Inc. (US) | 2021-12-08 | — | — | EP | disclosed |
| US-20210352892-A1 | MACROMOLECULAR AND NONPARTICULATE AGROCHEMICALS TO REDUCE VAPOR DRIFT | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2021-11-18 | — | — | US | disclosed |
| US-6319939-B1 | P-(HETEROCYCLIC METHYL)-SUBSTUTED ANILIDES ARE POTENT INHIBITORS OF THE RETINOIC ACID METABOLISM | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-11-20 | — | — | US | disclosed |
| CN-1057995-C | Substituted ortho-ethenylphenylacetic acid derivatives | BSAF AG (DE) | 2000-11-01 | — | — | CN | disclosed |
| EP-1037880-A1 | RETINOIC ACID MIMETIC ANILIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999029674-A1 | RETINOIC ACID MIMETIC ANILIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-06-17 | — | — | WO | disclosed |
| EP-0824504-A1 | IMPROVED DESTRUCTION OF ELECTRON AFFINIC CONTAMINANTS DURING WATER TREATMENT USING FREE RADICAL PROCESSES | Research Corporation Technologies, Inc (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996035642-A1 | IMPROVED DESTRUCTION OF ELECTRON AFFINIC CONTAMINANTS DURING WATER TREATMENT USING FREE RADICAL PROCESSES | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-11-14 | — | — | WO | disclosed |
| US-4267280-A | Controlled release pesticides and method of preparation | HOPKINS, MADISON WISCONSIN A CORP OF WISCONSIN | 1981-05-12 | — | — | US | disclosed |
| US-4225693-A | CONTROLLED RELEASE | HOPKINS AGRICULTURAL CHEMICAL COMPANY | 1980-09-30 | — | — | US | disclosed |
| US-4116665-A | Method of regulating the growth of aquatic weeds with pyridine derivatives | ELI LILLY AND COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322704-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | HBG2, HBG1, HBB | TRPV1 3983/4885IDO1 2927/4885TDO2 634/4885 |
| US-20210352892-A1 | MACROMOLECULAR AND NONPARTICULATE AGROCHEMICALS TO REDUCE VAPOR DRIFT | ACP1, PTMS, VDAC1 | TRPV1 1597/4885IDO1 2214/4885TDO2 906/4885 |
| US-11530191-B2 | Compounds and uses thereof for the modulation of hemoglobin | HBG2, HBG1, HBB | TRPV1 3983/4885IDO1 2927/4885TDO2 634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.